West Pharmaceutical Services Net Change in Cash decreased by 265.8% to -$269.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 235.7%, from -$80.40M to -$269.90M. Over 2 years (FY 2021 to FY 2025), Net Change in Cash shows an upward trend with a 44.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
A positive change indicates net cash generation, while a negative change indicates cash consumption for the period.
The total net increase or decrease in cash, cash equivalents, and restricted cash during the reporting period. It is the...
A fundamental liquidity metric used to compare cash management efficiency across all public companies.
net_change_in_cash| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $92.50M | $111.80M | $74.60M | -$94.90M | $165.30M | -$8.00M | -$90.00M | $102.30M | -$44.70M | -$252.10M | -$155.60M | -$6.30M | -$80.40M | $105.50M | $118.80M | $162.80M | -$269.90M |
| QoQ Change | — | +20.9% | -33.3% | -227.2% | +274.2% | -104.8% | <-999% | +213.7% | -143.7% | -464.0% | +38.3% | +96.0% | <-999% | +231.2% | +12.6% | +37.0% | -265.8% |
| YoY Change | — | — | — | — | +121.6% | +91.6% | — | — | -127.0% | <-999% | -72.9% | +85.9% | +68.1% | +167.8% | — | >999% | -235.7% |